WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018022815) TRANSDERMAL FORMULATION AND DELIVERY METHOD OF LOW SOLUBILITY OR UNSTABLE UNIONIZED NEUTRAL DRUGS BY IN SITU SALT-TO-NEUTRAL DRUG CONVERSION OF SALT DRUG
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/022815    International Application No.:    PCT/US2017/044048
Publication Date: 01.02.2018 International Filing Date: 26.07.2017
IPC:
A61K 9/70 (2006.01), A61K 31/13 (2006.01), A61K 31/445 (2006.01), A61K 31/137 (2006.01), A61K 31/18 (2006.01), A61K 31/27 (2006.01), A61P 25/00 (2006.01), A61P 25/28 (2006.01), A61P 25/16 (2006.01), A61P 25/04 (2006.01), A61P 25/24 (2006.01), A61P 25/22 (2006.01), A61P 25/36 (2006.01), A61P 35/00 (2006.01), A61P 13/00 (2006.01), A61P 13/02 (2006.01)
Applicants: CORIUM INTERNATIONAL, INC. [US/US]; 235 Constitution Drive Menlo Park, California 94025 (US)
Inventors: LEE, Eun Soo; (US).
JAIN, Amit K.; (US).
SINGH, Parminder; (US).
SAGI, Appala; (US)
Agent: MOHR, Judy M.; (US).
SNOW, Claine L.; (US).
LI, Wen; (US).
MAHONEY, Jacqueline F.; (US)
Priority Data:
62/367,542 27.07.2016 US
62/367,502 27.07.2016 US
62/423,133 16.11.2016 US
62/444,745 10.01.2017 US
62/444,763 10.01.2017 US
62/457,794 10.02.2017 US
62/504,408 10.05.2017 US
62/504,391 10.05.2017 US
Title (EN) TRANSDERMAL FORMULATION AND DELIVERY METHOD OF LOW SOLUBILITY OR UNSTABLE UNIONIZED NEUTRAL DRUGS BY IN SITU SALT-TO-NEUTRAL DRUG CONVERSION OF SALT DRUG
(FR) FORMULATION TRANSDERMIQUE ET PROCÉDÉ D'ADMINISTRATION D'UN MÉDICAMENT DE FORME NEUTRE NON IONISÉ DE FAIBLE SOLUBILITÉ OU INSTABLE PAR CONVERSION SEL DE MÉDICAMENT SUR PLACE D'UN MÉDICAMENT DE FORME NEUTRE À FORME SEL
Abstract: front page image
(EN)Compositions, devices, and methods for transdermal administration of active agents provided in their salt form instead of neutral form are provided.
(FR)La présente invention concerne des compositions, des dispositifs et des procédés d'administration transdermique d'agents actifs fournis sous forme de sel à la place d'une forme neutre.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)